Nordic Life Science asked some of the exhibitors at NLSDays about their experiences from the event. This time we spoke to Citoxlab and theit latest acquisition, Solvo Biotechnology.
Have you attended NLSDays before?
Citoxlab: “My company has attended before, but this is my first time.”
Solvo Biotechnology: “I have attended NLSDays a couple of times before, but this is the first time I am here as an exhibitor. So far I have been a basic participant, without a booth.”
What’s your experience from the event so far?
“It is a little quite in this corner where we have our booth, and it is hard to get partnering agreements when you are a service provider.”
Could you tell me a little bit about your companies?
Citoxlab: “We are a pre-clinical organization, headquartered in France, and with sites in Hungary, Denmark, Canada and the U.S. We have everything, from in vitro testing to later stages, in vivo. We have all you need before you go into clinical.”
Solvo Biotechnology: “We are one of Citoxlab’s most newest members, we just joined this year. We are based in Hungary and our focus is on in vitro transporter assays and related products.”